Connection

LAWRENCE DONEHOWER to Neoplasms

This is a "connection" page, showing publications LAWRENCE DONEHOWER has written about Neoplasms.
Connection Strength

1.353
  1. Integrated Analysis of TP53 Gene and Pathway Alterations in The Cancer Genome Atlas. Cell Rep. 2019 07 30; 28(5):1370-1384.e5.
    View in: PubMed
    Score: 0.238
  2. Insights into wild-type and mutant p53 functions provided by genetically engineered mice. Hum Mutat. 2014 Jun; 35(6):715-27.
    View in: PubMed
    Score: 0.162
  3. Effects of TP53 mutational status on gene expression patterns across 10 human cancer types. J Pathol. 2014 Apr; 232(5):522-33.
    View in: PubMed
    Score: 0.162
  4. Using mice to examine p53 functions in cancer, aging, and longevity. Cold Spring Harb Perspect Biol. 2009 Dec; 1(6):a001081.
    View in: PubMed
    Score: 0.121
  5. 20 years studying p53 functions in genetically engineered mice. Nat Rev Cancer. 2009 11; 9(11):831-41.
    View in: PubMed
    Score: 0.120
  6. EPIMUTESTR: a nearest neighbor machine learning approach to predict cancer driver genes from the evolutionary action of coding variants. Nucleic Acids Res. 2022 07 08; 50(12):e70.
    View in: PubMed
    Score: 0.073
  7. A general calculus of fitness landscapes finds genes under selection in cancers. Genome Res. 2022 05; 32(5):916-929.
    View in: PubMed
    Score: 0.071
  8. Mouse models in tumor suppression. Oncogene. 1998 Dec 24; 17(25):3385-400.
    View in: PubMed
    Score: 0.057
  9. Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas. Cell Rep. 2018 04 03; 23(1):239-254.e6.
    View in: PubMed
    Score: 0.054
  10. Recommended Guidelines for Validation, Quality Control, and Reporting of TP53 Variants in Clinical Practice. Cancer Res. 2017 03 15; 77(6):1250-1260.
    View in: PubMed
    Score: 0.050
  11. Genetic instability in animal tumorigenesis models. Cancer Surv. 1997; 29:329-52.
    View in: PubMed
    Score: 0.050
  12. Dynamic analyses of alternative polyadenylation from RNA-seq reveal a 3'-UTR landscape across seven tumour types. Nat Commun. 2014 Nov 20; 5:5274.
    View in: PubMed
    Score: 0.043
  13. The tumor suppressor p53. Biochim Biophys Acta. 1993 Aug 23; 1155(2):181-205.
    View in: PubMed
    Score: 0.039
  14. Mouse tissues that undergo neoplastic progression after K-Ras activation are distinguished by nuclear translocation of phospho-Erk1/2 and robust tumor suppressor responses. Mol Cancer Res. 2012 Jun; 10(6):845-55.
    View in: PubMed
    Score: 0.036
  15. p53: guardian AND suppressor of longevity? Exp Gerontol. 2005 Jan-Feb; 40(1-2):7-9.
    View in: PubMed
    Score: 0.022
  16. p53 mutant mice that display early ageing-associated phenotypes. Nature. 2002 Jan 03; 415(6867):45-53.
    View in: PubMed
    Score: 0.018
  17. Cancer prevention studies in p53-deficient mice. Toxicol Pathol. 2001 Jan-Feb; 29(1):137-41.
    View in: PubMed
    Score: 0.016
  18. Impact papers on aging in 2009. Aging (Albany NY). 2010 Mar; 2(3):111-21.
    View in: PubMed
    Score: 0.008
  19. Widespread and tissue specific age-related DNA methylation changes in mice. Genome Res. 2010 Mar; 20(3):332-40.
    View in: PubMed
    Score: 0.008
  20. Generation and characterization of p53 mutant mice. Methods Mol Biol. 2003; 234:29-49.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.